MetLife Investment Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Sell |
39,992
-181
| -0.5% | -$2.03K | ﹤0.01% | 1731 |
|
|
2025
Q1 | $184K | Hold |
40,173
| – | – | ﹤0.01% | 2248 |
|
|
2024
Q4 | $227K | Hold |
40,173
| – | – | ﹤0.01% | 2245 |
|
|
2024
Q3 | $194K | Hold |
40,173
| – | – | ﹤0.01% | 2302 |
|
|
2024
Q2 | $196K | Buy |
40,173
+5,910
| +17% | +$28.8K | ﹤0.01% | 2255 |
|
|
2024
Q1 | $455K | Buy |
34,263
+7,205
| +27% | +$95.7K | ﹤0.01% | 1727 |
|
|
2023
Q4 | $377K | Hold |
27,058
| – | – | ﹤0.01% | 1849 |
|
|
2023
Q3 | $359K | Hold |
27,058
| – | – | ﹤0.01% | 1834 |
|
|
2023
Q2 | $507K | Buy |
27,058
+2,381
| +10% | +$44.6K | ﹤0.01% | 1682 |
|
|
2023
Q1 | $356K | Hold |
24,677
| – | – | ﹤0.01% | 1859 |
|
|
2022
Q4 | $478K | Hold |
24,677
| – | – | ﹤0.01% | 1674 |
|
|
2022
Q3 | $848K | Buy |
24,677
+3,739
| +18% | +$128K | 0.01% | 1276 |
|
|
2022
Q2 | $320K | Hold |
20,938
| – | – | ﹤0.01% | 1978 |
|
|
2022
Q1 | $478K | Buy |
20,938
+15,124
| +260% | +$345K | ﹤0.01% | 1797 |
|
|
2021
Q4 | $214K | Hold |
5,814
| – | – | ﹤0.01% | 2012 |
|
|
2021
Q3 | $273K | Buy |
+5,814
| New | +$273K | ﹤0.01% | 1883 |
|